Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/07/2006US7132586 Protein production system
11/07/2006US7132539 Melanocortin receptor ligands
11/07/2006US7132526 Comprises anther specific regulatory sequences for use as control agents for expression of heterologous nucleotide sequences in plants; disease resistant plants
11/07/2006US7132525 Isolated DNA molecule encoding a fragment of an Erwinia hypersensitive response elicitor protein or polypeptide, to elicit hypersensitive response in the plants
11/07/2006US7132524 Plant brassinolide responsive genes and use thereof
11/07/2006US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006US7132514 Electrophoresis and Western blotting to detect material which binds to capsid anti-protein monoclonal antibody
11/07/2006US7132512 Medicament for the treatment of chlamydial infection
11/07/2006US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006US7132509 Colon specific gene and protein
11/07/2006US7132508 Mammalian chemokine reagents
11/07/2006US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006US7132505 Milking Psalmopoeus cambridgei spider to obtain venom, separating toxins by reverse-phase chromatography, ion exchaning, isolating, the adding carrier
11/07/2006US7132407 N'-neu-IL-2 fusion gene controlled by a cytomegalo virus promoter
11/07/2006US7132401 Beta-secretase substrates and uses thereof
11/07/2006US7132399 Mammalian cell surface DNA receptor
11/07/2006US7132397 Bone morphogenetic protein antagonist based on the mature protein
11/07/2006US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006US7132394 parathyroid hormone (PTH) analogscomprising oligopeptides, useful for the treatment of hypoparathyroidism and bone disorders, such as osteoporosis, and for stimulating repair bone fractures or grafting of implants
11/07/2006US7132292 Anther-specific promoter from the rice TUB8 gene and uses thereof
11/07/2006US7132280 Genetically engineered cell for use in the generation of vaccines against bacterial and viral infections
11/07/2006US7132276 Human p51 genes and gene products thereof
11/07/2006US7132274 Method for identifying modulators of CLK-1 and UbiF activity
11/07/2006US7132273 polynucleotides codes, cells transformed with genetic vectors and gene expression of heterologous polypeptides or proteins on the surfaces of cells; biochemical immobilization; biocatalysts; altering target protein characteristics such as binding affinity and stability by library screening
11/07/2006US7132272 Nucleotide sequence encoding corynebacterium glutamicum leucine response regulatory protein
11/07/2006US7132271 Methods for enhancing the production of viral vaccines in cell culture
11/07/2006US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006US7132263 Expression vectors comprising nucleotide sequences coding polypeptides which confer freeze resistance and tolerance; generation and propagation of cold tolerant crop plants
11/07/2006US7132262 administering codon optimized polynucleotides that code human papillomavirus polypeptides comprising early proteins or fragments to cells of mammals; gene therapy; DNA vaccines
11/07/2006US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006US7132260 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
11/07/2006US7132259 nucleic acids encoding neurotoxin polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; for biosynthesis of botulinum neurotoxins in host cells
11/07/2006US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006US7132248 Uses of galanin GALR2 receptors
11/07/2006US7132246 Use of soluble cytokeratin-1-fragments in diagnostics and therapy
11/07/2006US7132245 Organ transplant rejection and associated conditions
11/07/2006US7132244 Biopolymer marker for use in diagnosis of genetic disorders
11/07/2006US7132237 Avian leukosis viruses and polypeptide display
11/07/2006US7132233 using capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome
11/07/2006US7132109 Administering to the subject a vaccine comprising component against which an immune response is desired to be induced; administering to the subject a heat shock protein preparation which does not display immunogenicity of the component
11/07/2006US7132107 For prophylaxis and therapy of prevention and pneumococcal infection
11/07/2006US7132106 Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
11/07/2006US7132105 Icosahedral superstructure of VP2 of infectious bursitis virus (IBDV) and the application thereof
11/07/2006US7132102 Bacteriocin isolated from Lactobacillus salivarius deposited with United States Department of Agricultural, Agricultural Research Service Patent Culture Collection as Accession Number NRRL-B30514; used for reducing the levels of colonization by a target bacteria in animals, especially poultry
11/07/2006US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006US7132099 Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
11/07/2006US7132098 Administering a glycosidase that degrades chondroitin sulfate or hyaluronic acid to an intervertebral disk having a nucleus pulposus and an annulus fibrosus, adminstering a growth factor within 24 hours to stimulate formation of a matrix
11/07/2006CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006CA2226436C Generation of immune responses to prostate-specific antigen (psa)
11/07/2006CA2183856C Tcf mutant
11/07/2006CA2128511C Monomeric and dimeric antibody-fragment fusion proteins
11/02/2006WO2006116737A2 Compounds and methods for modulating cadherin-mediated processes
11/02/2006WO2006116727A2 Compositions and methods for detection of sirolimus
11/02/2006WO2006116292A2 Methods for reducing the immunogenicity of cytokines and removal of cell surface markers
11/02/2006WO2006116202A1 Materials and methods for engineering resistance to tomato yellow leaf curl virus (tylcv) in plants
11/02/2006WO2006116181A2 Regulatory t cell mediator proteins and uses thereof
11/02/2006WO2006116082A1 Materials and methods for respiratory disease control in canines
11/02/2006WO2006115633A2 Cyanine-chlorotoxin conjugate and method for intra-operative fluorescent visualization of cancer
11/02/2006WO2006115548A2 Subunit vaccine against west nile viral infection
11/02/2006WO2006115413A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006WO2006115153A1 Food composition having skin condition-improving effect
11/02/2006WO2006115026A1 Humanin receptor or humanin-like polypeptide receptor
11/02/2006WO2006114799A1 Synthetic peptides for the diagnosis and therapy of berillium granulomatous disease
11/02/2006WO2006114647A1 Ion chann
11/02/2006WO2006114616A1 Engineered peroxidases with veratryl alcohol oxidase activity
11/02/2006WO2006114434A1 Use of elongator genes to enhance vigour and stress tolerance in eukaryotic cells
11/02/2006WO2006114324A1 Compounds comprising cyclized somatostatin receptor binding peptides
11/02/2006WO2006114308A2 Carrier for targeting nerve cells
11/02/2006WO2006114307A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006WO2006114039A1 Method for separating nisin from fermantation liquid of lactic galactococcus
11/02/2006WO2006097336A9 A novel component of the wg/wnt signaling pathway
11/02/2006WO2006089801A3 Method for the redox potential-dependent detection of target molecules by interactive peptides
11/02/2006WO2006086769A3 Gip analog and hybrid polypeptides with selectable properties
11/02/2006WO2006084712A3 Novel gene rcs 27
11/02/2006WO2006084711A3 Novel gene sts 22
11/02/2006WO2006084643A3 Novel gene vcs 07
11/02/2006WO2006079929A3 Therapeutic peptides derived from urokinase plasminogen activator receptor
11/02/2006WO2006076902A3 Recombinant expression of proteins in a disulfide-bridged, two-chain form
11/02/2006WO2006074389A3 Four-helical bundle protein zsig99
11/02/2006WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006WO2006042027A8 Immunogenic and therapeutic compositions for streptococcus pyogenes
11/02/2006WO2006040357A3 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/02/2006WO2006034373A3 Variants and chemically-modified variants of phenylalanine ammonia-lyase
11/02/2006WO2006032909A3 Pka ii anchoring disruption polypeptide
11/02/2006WO2006025718A3 Immunogen and antivenom against violin spider venom
11/02/2006WO2005110493A8 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
11/02/2006WO2005060479A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
11/02/2006WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006US20060248617 Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same
11/02/2006US20060248616 Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants
11/02/2006US20060248615 Synthetic spider silk proteins and expression thereof in transgenic plants
11/02/2006US20060248614 Implementation of a mitochondrial mutator
11/02/2006US20060248613 Implementation of a mitochondrial mutator
11/02/2006US20060248612 modulating properties of fruit dehiscence in plants, particularly Brassicaceae plants, specifically improving means for reducing seed shattering, or reducing seed shattering until after harvest, in plants, particularly the Brassicaceae plants grown for oil production
11/02/2006US20060248610 Fungus resistant plants and their uses
11/02/2006US20060248608 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
11/02/2006US20060248607 CCR6 chemokine receptor disruptions, compositions and methods relating thereto
11/02/2006US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same